Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Including androgens in hormone therapy may lower breast cancer risk.

New treatments for hair loss focus on targeting specific causes to improve effectiveness and safety.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

A new peptide, FOL-005, may help treat excessive hair growth by reducing a hair growth promoter, FGF7.

HNG helps hair grow by keeping hair in the growth phase longer.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

EX104 shows promise in treating hair loss by promoting hair growth and improving scalp health.

Dienogest combined with ethinylestradiol is a highly effective birth control that improves menstrual symptoms and has manageable side effects.

New treatments like PBMC, G-CSF, and PRP show promise for helping with repeated implantation failure.

The new assay can help develop products for hair re-growth.

New steroid derivatives show promise as anticancer agents, even against resistant cells.

Nanoparticle delivery can reduce side effects of the cancer drug doxorubicin.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

GTx-024 and Danazol affect the uterus like DHT, while GTx-007 has little impact.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Cyproterone acetate can effectively treat idiopathic hirsutism, but ethinyl oestradiol and lynoestrenol may not always reduce hair growth.

Injecting endometrial cells and PRP can improve pregnancy chances in ART.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Cyproterone acetate with estradiol may subjectively improve excessive hair growth in women, but it's not clinically better than other treatments.